LCD L38268: Immune Thrombocytopenia (ITP) Therapy — CGS
Policy LCD-L38268 · Hematology
New LCD for ITP effective March 2026 impacts billing practices.
Code intelligence
Policy changes, MAC LCD updates, and CMS guidance matched to code J1599.
Signal breakdown
6 shown · 6 total in platform
Critical
0%
High
17%
Routine
83%
Low
0%
New this month
—
alerts added in last 30 days
Effective soon
—
no upcoming deadlines
Policy LCD-L38268 · Hematology
New LCD for ITP effective March 2026 impacts billing practices.
Policy LCD-L34074 · Neurology
Key billing updates for IVIg reimbursement by Noridian.
Policy LCD-L34314 · Hematology
Prepare for changes in IVIg billing practices and compliance.
Policy LCD-L34771 · Outpatient
New LCD for Immune Globulins impacts billing structure.
Policy LCD-DL39314 · Allergy/Immunology
Impact of off-label IVIG use on Medicare billing.
Policy LCD-L39314 · Allergy/Immunology
New LCD impacts IVIG billing practices for off-label uses.
Audit documentation
The Tripwire Audit Pack exports 12 months of Hematology policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.